Glioblastoma
Showing NaN - NaN of 55
High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Standard Radiotherapy and TMZ Patients With GBM
Not yet recruiting
- Glioblastoma
- Glioma, Malignant
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University
Jan 20, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))
Available
- Pancreatic Cancer
- +20 more
- Ulixertinib (BVD-523)
-
Birmingham, Alabama
- +25 more
Nov 4, 2022
Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)
Recruiting
- Malignant Glioma
- Glioblastoma
-
Durham, North CarolinaDuke University Medical Center
Oct 13, 2022
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria
Suspended
- Glioblastoma
- Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
- +4 more
-
Durham, North CarolinaDuke University Medical Center
Aug 16, 2022
Marrow and Blood in Patients With Glioblastoma
Not yet recruiting
- Glioblastoma
- Biorepository
-
Durham, North CarolinaDuke University Medical Center
Jul 28, 2022
GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))
Completed
- GBM
- +3 more
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
-
Durham, North CarolinaDuke University Medical Center
Jun 28, 2022
Glioblastoma Trial in Durham (PVSRIPO)
No longer available
- Glioblastoma
- PVSRIPO
-
Durham, North CarolinaDuke University Medical Center
Jun 23, 2022
Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)
Not yet recruiting
- Malignant Glioma
- Glioblastoma
- hEGFRvIII-CD3 (BRiTE)
- Activated Cell Therapy
-
Durham, North CarolinaDuke University Medical Center
Jun 24, 2022
Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)
Not yet recruiting
- Glioblastoma
- Glioma, Malignant
- MT-201-GBM monocyte vaccine
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022
Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))
Completed
- Malignant Glioma
- +2 more
- Bevacizumab
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022
Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed
Completed
- Glioblastoma
- +3 more
- Unpulsed DCs
- +6 more
-
Durham, North CarolinaDuke University Medical Center
Jan 3, 2022
Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,
Recruiting
- Glioblastoma Multiforme
- +4 more
- pp65-shLAMP DC with GM-CSF
- +4 more
-
Gainesville, Florida
- +2 more
Jan 6, 2022
Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)
Active, not recruiting
- Glioblastoma
- +3 more
- lerapolturev
- pembrolizumab
-
San Francisco, California
- +9 more
Nov 30, 2021
Malignant Glioma, Grade 4 Malignant Glioma, Glioblastoma Trial in Durham (Radiation Therapy, Temozolomide, Bevacizumab)
Completed
- Malignant Glioma
- +3 more
- Radiation Therapy
- +2 more
-
Durham, North CarolinaDuke Cancer Center
Jan 6, 2021
Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)
Completed
- Glioblastoma
-
Los Angeles, California
- +7 more
Nov 30, 2020
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),
Completed
- B-cell Malignancies
- +7 more
- Nivolumab (Phase 1)
- +4 more
-
Birmingham, Alabama
- +23 more
Aug 26, 2020
Glioblastoma, Gliosarcoma Trial in Durham (EGFRvIII CAR T cells)
Terminated
- Glioblastoma
- Gliosarcoma
- EGFRvIII CAR T cells
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center at Duke
Jul 8, 2020